1. Home
  2. MCRB vs TBI Comparison

MCRB vs TBI Comparison

Compare MCRB & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$9.42

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$3.63

Market Cap

129.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCRB
TBI
Founded
2010
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
129.9M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
MCRB
TBI
Price
$9.42
$3.63
Analyst Decision
Hold
Buy
Analyst Count
3
1
Target Price
$14.33
$6.00
AVG Volume (30 Days)
46.0K
273.6K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.39
EPS
0.64
N/A
Revenue
$789,000.00
N/A
Revenue This Year
N/A
$6.25
Revenue Next Year
N/A
$3.90
P/E Ratio
$14.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$3.44
52 Week High
$29.98
$7.78

Technical Indicators

Market Signals
Indicator
MCRB
TBI
Relative Strength Index (RSI) 43.72 33.19
Support Level $6.99 $3.44
Resistance Level $9.60 $5.56
Average True Range (ATR) 0.53 0.24
MACD 0.24 -0.02
Stochastic Oscillator 77.57 12.39

Price Performance

Historical Comparison
MCRB
TBI

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

Share on Social Networks: